These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The psychopharmacology of social phobia and comorbid disorders. Rosenbaum JF, Pollock RA. Bull Menninger Clin; 1994 Mar; 58(2 Suppl A):A67-83. PubMed ID: 7913851 [Abstract] [Full Text] [Related]
3. The pharmacologic treatment of anxiety disorders: a review of progress. Ravindran LN, Stein MB. J Clin Psychiatry; 2010 Jul; 71(7):839-54. PubMed ID: 20667290 [Abstract] [Full Text] [Related]
4. Comorbidity, neurobiology, and pharmacotherapy of social anxiety disorder. Pollack MH. J Clin Psychiatry; 2001 Jul; 62 Suppl 12():24-9. PubMed ID: 11430615 [Abstract] [Full Text] [Related]
5. [Behavior therapy and antidepressive drugs. What helps with anxiety?]. Bandelow B. MMW Fortschr Med; 2002 May 06; Suppl 2():60-2, 64-5. PubMed ID: 12070854 [Abstract] [Full Text] [Related]
6. Pharmacotherapy of social anxiety disorder: what does the evidence tell us? Davidson JR. J Clin Psychiatry; 2006 May 06; 67 Suppl 12():20-6. PubMed ID: 17092192 [Abstract] [Full Text] [Related]
7. Integrating neurobiology and psychopathology into evidence-based treatment of social anxiety disorder. Liebowitz MR, Ninan PT, Schneier FR, Blanco C. CNS Spectr; 2005 Oct 06; 10(10):suppl13 1-11; discussion 12-3; quiz 14-5. PubMed ID: 16404800 [Abstract] [Full Text] [Related]
8. Issues and controversies surrounding the diagnosis and treatment of social anxiety disorder. Dalrymple KL. Expert Rev Neurother; 2012 Aug 06; 12(8):993-1008; quiz 1009. PubMed ID: 23002942 [Abstract] [Full Text] [Related]
9. Cognitive-behavioral therapy modifies the naturalistic course of social anxiety disorder: findings from an ABA design study in routine clinical practices. Furukawa TA, Nakano Y, Funayama T, Ogawa S, Ietsugu T, Noda Y, Chen J, Watanabe N, Akechi T. Psychiatry Clin Neurosci; 2013 Apr 06; 67(3):139-47. PubMed ID: 23581864 [Abstract] [Full Text] [Related]
10. Pregabalin for the treatment of social anxiety disorder. Kawalec P, Cierniak A, Pilc A, Nowak G. Expert Opin Investig Drugs; 2015 Apr 06; 24(4):585-94. PubMed ID: 25361817 [Abstract] [Full Text] [Related]
11. Pharmacotherapy of social anxiety disorder. Ganasen KA, Stein DJ. Curr Top Behav Neurosci; 2010 Apr 06; 2():487-503. PubMed ID: 21309123 [Abstract] [Full Text] [Related]
12. Psychopharmacology of the anxiety disorders. Ballenger JC. Psychiatr Clin North Am; 1984 Dec 06; 7(4):757-71. PubMed ID: 6151647 [Abstract] [Full Text] [Related]
13. Treatment of social phobias. Agras WS. J Clin Psychiatry; 1990 Oct 06; 51 Suppl():52-5; discussion 56-8. PubMed ID: 1976625 [Abstract] [Full Text] [Related]
14. A review of the epidemiology and approaches to the treatment of social anxiety disorder. Sareen L, Stein M. Drugs; 2000 Mar 06; 59(3):497-509. PubMed ID: 10776832 [Abstract] [Full Text] [Related]
16. Relative effects of CBT and pharmacotherapy in depression versus anxiety: is medication somewhat better for depression, and CBT somewhat better for anxiety? Roshanaei-Moghaddam B, Pauly MC, Atkins DC, Baldwin SA, Stein MB, Roy-Byrne P. Depress Anxiety; 2011 Jul 07; 28(7):560-7. PubMed ID: 21608087 [Abstract] [Full Text] [Related]
18. Social anxiety disorder: epidemiology, biology and treatment. Fink M, Akimova E, Spindelegger C, Hahn A, Lanzenberger R, Kasper S. Psychiatr Danub; 2009 Dec 07; 21(4):533-42. PubMed ID: 19935490 [Abstract] [Full Text] [Related]
19. Social anxiety disorder: designing a pharmacologic treatment strategy. Pollack MH. J Clin Psychiatry; 1999 Dec 07; 60 Suppl 9():20-6. PubMed ID: 10335676 [Abstract] [Full Text] [Related]
20. Comorbidity of mood and anxiety disorders. Kaufman J, Charney D. Depress Anxiety; 2000 Dec 07; 12 Suppl 1():69-76. PubMed ID: 11098417 [Abstract] [Full Text] [Related] Page: [Next] [New Search]